Third Rock Ventures — 2020 Investments
5 investments dated 2020 · listed companies and verified rows first · show all
BiotechCambridge, US
Alexandra Glucksmann(Executive Officer, Director)Dominik Naczynski(Director)Chris Bowden(Director)Jake Simson(Director)Rosana Kapeller(Director)
Board seatAbbie CelnikerNeil Exter· per SEC Form D · $82.6M raise · filed Oct 2021
Co-investorsCasdin Capital
BiotechCambridge, US
Ed Freedman(Executive Officer, Director)
BoardCary Pfeffer(Executive Officer, Director)in
PartnerCary Pfeffer· quoted
Board seatCharles HomcyRobert Tepper· per SEC Form D
HealthtechCambridge, US
PETER THOMSON(Executive Officer)
BoardLOUIS BRENNER(Director)
Board seatAbbie CelnikerNeil Exter· per SEC Form D · filed Jul 2020
BiotechHealthtechCambridge, US
Barry Greene(Executive Officer, Director)Kimi Iguchi(Executive Officer)Michael Cloonan(Executive Officer)Anne Marie Cook(Executive Officer)Stephen J. Kanes(Executive Officer)Jeffrey M. Jonas(Executive Officer, Director)
Board seatKevin Starr· per SEC Form D · $650M raise · filed Jan 2021
insitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines.
AI & Machine LearningBiotechSouth San Francisco, US
Daphne Koller(CEO & Founder)inDuane Valz(General Counsel)Mary Rozenman(Chief Financial Officer)
BoardRobert Nelsen(Director)Vijay Pande(Director)in
Co-investorsAndreessen HorowitzARCH Venture PartnersForesite CapitalGV (Google Ventures)HOF CapitalSoftBank Vision Fund+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.